This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Coaches' Corner: Critical Communication Issues and Strategies in Atopic Dermatitis

Coaches' Corner: Critical Communication Issues and Strategies in Atopic Dermatitis

Format

Patient Case Simulations

Time to Complete

1 hour

Released

June 19, 2019

Expires

June 19, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour
1.00 / CE for Nurse Practitioners (0.30 pharmacology hour)
1.00 / CE for Pharmacists

Accredited Provider

This activity is jointly provided by Global Education Group and FactorX in partnership with National Eczema Association.

Commercial Supporter

This activity is supported by an educational grant provided by Pfizer Inc.

Program Description

Evidence supports an active role for patients in managing their healthcare decisions based on an informed understanding of risks and benefits. Because active, patient-centered cooperation of atopic dermatitis (AD) therapy is critical for successful outcomes, it is essential to involve patients in management decisions based on an informed understanding of risks and benefits. Shared decision-making (SDM) has the potential to provide numerous benefits for patients, clinicians, and the healthcare system. However, many clinicians do not understand the rationale or benefit for its use. In this activity, guidance for SDM will be provided from both the patient and provider perspectives. Video vignettes with clinicians and AD patients provide learners with examples of effective communication and the SDM strategies, providing examples of effective and efficient patient/provider discussions, and resulting in better patient outcomes.

Click here for a downloadable resource for your patients (PDF)

Intended Audience

The target audience for this initiative includes allergists (pediatric and adult), dermatologists (pediatric and adult), pediatricians, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists and other healthcare providers involved in the care and management of patients with atopic dermatitis as well as patients with atopic dermatitis.

Educational Objectives

At the conclusion of this educational activity, participants should be able to:

  • Describe the rationale and benefits for shared decision-making (SDM) in the care of patients with AD
  • Identify strategies for implementing SDM with their AD patients
  • Express how implementing SDM with their AD patients can lead to improved patient outcomes
  • Describe how to encourage patients to enroll in the National Eczema Association website and platform

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Lawrence F. Eichenfield, MD
Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
Chief, Pediatric and Adolescent Dermatology
University of California, San Diego School of Medicine
San Diego, CA

Dr. Eichenfield discloses the following:
Advisor or Consultant: Allergan, Anacor/Pfizer, Dermavant, Dermira, DS Biopharma, Forte, Galderma Labs, Incyte, Leo Pharma, Lily, Matrisys, Medimetriks/Otsuka, Menlo Therapeutics, Novan, Novartis, Otsuka/Medimetriks, Sanofi/Regeneron, TopMD, Ortho Dermatologics, Glenmark

Jonathan Spergel, MD, PhD
Professor of Pediatrics
Perelman School of Medicine at University of Pennsylvania
Chief, Allergy Section
The Children’s Hospital of Philadelphia
Philadelphia, PA

Dr. Spergel discloses the following:
Advisor or Consultant: Medscape, Genentech, Regeneron
Speaker’s Bureau: Medscape

Jennifer LeBovidge, PhD
Psychologist, Atopic Dermatitis Center and Food Allergy Program
Boston Children's Hospital
Assistant Professor of Psychology
Harvard Medical School
Boston, MA

Dr. LeBovidge discloses the following:
Clinical Research: Pfizer, Inc.

Peter Lio, MD
Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Physician
Medical Dermatology Associates of Chicago
Chicago, IL

Dr. Lio discloses the following:
Advisor or Consultant: AbbVie, AOBiome, Galderma, Johnson & Johnson, Kiniksa, La Roche-Posay, L’Oreal, Menlo, Pfizer, Pierre Fabre, Regeneron, Sanofi, Valeant
Speaker’s Bureau: La Roche-Posay,Pfizer, Regeneron, Sanofi
Clinical Research: AOBiome, The Atopic Dermatitis Foundation

Paul Doghramji, MD, FAAFP
Senior Family Physician
Collegeville Family Practice
Medical Director
Ursinus College
Collegeville, PA

Dr. Doghramji has nothing to disclose.

Maysel Kemp White, PhD, MFT, FAACH
Founder
Healthcare Quality and Communication Improvement, LLC
Clearwater Beach, FL

Dr. White has nothing to disclose.

Alexis Smith
Patient

Alexis Smith has nothing to disclose.

Stephen Gawron
Patient

Stephen Gawron has nothing to disclose.

Raelle Brown
Patient

Raelle Brown has nothing to disclose.

Accredited Provider Discosures

Ashley Marostica, RN, MSN, has nothing to disclose.
Kristin Delisi, NP, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Liddy Knight has nothing to disclose.
Ashley Cann has nothing to disclose.

Publishing Staff Disclosures

Dan Duch, PhD, has nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and FactorX. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurse Practitioners

Accreditation Statement


This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and FactorX. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024.

Designation Statement

This activity is approved for 1.0 contact hour which includes 0.30 hours of pharmacology.

Activity ID #2702E.

This activity was planned in accordance with AANP CE Standards and Policies.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Global Education Group designates this continuing education activity for 1.00 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-19-063-H01-P)

This is a knowledge-based activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and FactorX do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Term of Offering

This activity was released on 6/19/19 and is valid for one year. Requests for credit must be made no later than 6/19/20.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue